Skip to content

Association Study of Genetic Polymorphisms in Serotonin System with Suicide Attempts in Major Depressive Disorder Patients Aiming to Utilize the Genetic Markers for Predicting Suicide Risk in the Thai Population

Association Study of Genetic Polymorphisms in Serotonin System with Suicide Attempts in Major Depressive Disorder Patients Aiming to Utilize the Genetic Markers for Predicting Suicide Risk in the Thai Population

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20260710006
Enrollment
300
Registered
2026-07-10
Start date
2026-05-04
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The study includes patients diagnosed with either Major Depressive Disorder (MDD) or Persistent Depressive Disorder (PDD) based on DSM-5-TR criteria, including those with and without a history of suicide attempts. Major Depressive Disorder (MDD) Persistent Depressive Disorder (PDD) Suicide Gene polymorphism Serotonergic system

Interventions

1. Male/female volunteers aged between 18 and 65 years. 2. Volunteers who do not have severe stress based on the Stress Assessment Form (SPST-20). 3. Volunteers who consent to participate in the res
Healthy volunteers,Depressed patients without suicidal history,Depressed patients with suicidal history

Sponsors

Naresuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Experimental Group (Depressed Patients) 1. Male or female patients with depression aged 18 to 65 years 2. Patients diagnosed with Major Depressive Disorder (MDD) or Persistent Depressive Disorder (PDD) by a psychiatrist according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) 3. Patients who voluntarily agree to participate in the study and provide written informed consent 4. Patients who can read, listen, and write in the Thai language Control Group (Healthy Volunteers) 1. Male or female patients with depression aged 18 to 65 years 2. Volunteers without severe stress, as determined by the Suanprung Stress Test-20 (SPST-20) 3. Volunteers who voluntarily agree to participate in the study 4. Volunteers who can read, listen, and write in the Thai language

Exclusion criteria

Exclusion criteria: Experimental Group (Depressed Patients) 1. Patients with severe depression who are unable to provide informed consent 2. Patients with a history of substance abuse (e.g., methamphetamine, ecstasy, cannabis, heroin, opium, morphine, cocaine, kratom, or inhalants) within the past 6 months 3. Patients with a history of chronic alcoholism (Alcohol Use Disorder) 4. Patients who are currently pregnant 5. Patients who are unwilling to provide information Control Group (Healthy Volunteers) 1. Volunteers with stress or anxiety, as determined by the Suanprung Stress Test-20 (SPST-20), reaching a severe level 2. Volunteers with a history of substance abuse (e.g., methamphetamine, ecstasy, cannabis, heroin, opium, morphine, cocaine, kratom, or inhalants) within the past 6 months 3. Volunteers with a history of chronic alcoholism (Alcohol Use Disorder) 4. Volunteers who are currently pregnant 5. Volunteers who are unwilling to provide information

Design outcomes

Primary

MeasureTime frame
Correlation between genetic polymorphisms in serotonin system and suicide attempts in major depressive disorder patients at enrollment to each group Real-Time PCR System

Secondary

MeasureTime frame
Correlation between genetic polymorphisms in serotonin system and major depressive disorder patients at enrollment to each group Real-Time PCR System

Countries

Thailand

Contacts

Public ContactSutisa Thanoi

Faculty of Medical Science, Naresuan University

Sutisat@nu.ac.th055964784

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026